|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.83/-2.67
|
企业价值
398.26M
|
资产负债 |
每股账面净值
4.42
|
现金流量 |
现金流量率
--
|
损益表 |
收益
100.39M
|
每股收益
2.85
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/12/24 12:49 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer. |